Oral delivery of discrete units

• US 5,780,058 A
• Filed: 07/19/1996
• Issued: 07/14/1998
• Est. Priority Date: 07/21/1995
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Wong, Patrick S.-L., Rosen, Howard B., Gardner, Phyllis I., Roth, Nathan
• Primary Examiner(s): BROUILLETTE, D GABRIELLE
• Application Number:
  US08/684,602
• Time in Patent Office: 725 Days
• Field of Search: 424/473, 424/438, 424/451, 424/464
• US Class Current: 424/473
• CPC Class Codes: A47G 21/183 with means for changing the flavour of the liquid
• CPC Class Codes: A61J 7/0038 Straws
• CPC Class Codes: A61K 9/0092 Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Abstract

The present invention is directed to an oral active agent delivery system and method for delivering discrete units of an active agent formulation to a patient. An active agent formulation chamber (10) containing the active agent formulation and having a fluid passing active agent formulation retainer (14) is placed at one end (16) into a fluid and at a second end (18) into a patient'"'"'s mouth. The active agent is delivered when the patient sips on the end of the chamber.

Claims

1. An oral active agent delivery system for delivering to a patient discrete units of active agent formulation in admixture with a fluid, said system comprising:

a tubular active agent formulation chamber, said chamber having a first end and a second end and containing an active agent formulation in the form of discrete units, said first end being adapted for fluid communication with a fluid and said second end being adapted for oral application of suction by the patient; and

a fluid passing active agent formulation retainer in said active agent formulation chamber for preventing release of the discrete units from the first end of the chamber while permitting fluid entry into the chamber, said retainer being transportable toward said second end of said chamber with the fluid entering said first end of said chamber upon application of suction at said second end.

2. The delivery system of claim 1 further comprising an active agent formulation retainer in the second end of the active agent formulation chamber for preventing release of said active agent formulation from said second end prior to use.

3. The delivery system of claim 2 wherein said active agent formulation retainer in the second end of the chamber comprises a rotary valve.

4. The delivery system of claim 2 wherein said active agent formulation retainer in the second end of the chamber comprises a narrowing in the second end of the chamber.

5. The delivery system of claim 2 wherein said active agent formulation retainer in the second end of the chamber comprises a removable end cap.

6. The delivery system of claim 1 wherein said discrete units are selected from the group consisting of particulates, oral dosage forms and combinations thereof.

7. The delivery system of claim 1 wherein said discrete units provide for prolonged delivery of the active agent in said formulation.

8. The delivery system of claim 1 wherein said discrete units provide for immediate delivery of the active agent in said formulation.

9. The delivery system of claim 1 wherein said discrete units provide for delayed pulsed delivery of said active agent in said formulation.

10. The delivery system of claim 1 wherein said discrete units comprise oral dosage forms that comprise an osmotic layer and an active agent layer.

11. The delivery system of claim 1 further wherein said active agent formulation retainer comprises a one-way plug.

12. The delivery system of claim 11 wherein the position of the plug is an indicator of the extent of active agent delivery.

13. The delivery system of claim 1 further comprising an end cap concentrically surrounding the first end of the chamber.

14. The delivery system of claim 1 wherein said active agent formulation comprises an active agent selected from the group consisting of antibiotics, antiviral agents, anepileptics, analgesics, anti-inflammatory agents and bronchodilators.

15. A method for observing the delivery to a patient of a dose of active agent formulation in admixture with a liquid from a delivery system comprising a tubular member containing the active agent formulation and a transportable active agent formulation retainer positioned between the active agent formulation and the liquid, wherein the method comprises:

observing a first position of the active agent formulation retainer within the tubular member and observing a second position of the retainer within the tubular member after

suctioning liquid through the tubular member upon oral application of sucking by the patient, and

removing the suction.